Skip to main content
Top

Drugs

Issue 5/2017

Content (9 Articles)

Therapeutic Options in Refractory Diabetic Macular Oedema

  • Current Opinion

Sanket U. Shah, Raj K. Maturi

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

  • Open Access
  • Leading Article

Bruno Geloneze, José Carlos de Lima-Júnior, Lício A. Velloso

JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

  • Review Article

Shubhasree Banerjee, Ann Biehl, Massimo Gadina, Sarfaraz Hasni, Daniella M. Schwartz

The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus

  • Open Access
  • Review Article

David A. Johnson, Philip O. Katz, David Armstrong, Henry Cohen, Brendan C. Delaney, Colin W. Howden, Peter Katelaris, Radu I. Tutuian, Donald O. Castell

Rucaparib: First Global Approval

  • AdisInsight Report

Yahiya Y. Syed

Plecanatide: First Global Approval

  • AdisInsight Report

Zaina T. Al-Salama, Yahiya Y. Syed

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images